Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Novanta ( (NOVT) ) has shared an update.
Novanta Inc. reported its financial results for the second quarter of 2025, showing a 2% increase in GAAP revenue to $241 million and a GAAP net income of $4.5 million. Despite the challenging macroeconomic environment, the company achieved a 10% growth in bookings and a book-to-bill ratio of 1.02, indicating a positive outlook. The results reflect the company’s ability to meet or exceed expectations in revenue, margins, and profitability, with significant growth in its Advanced Surgery and Robotics & Automation segments.
The most recent analyst rating on (NOVT) stock is a Hold with a $175.00 price target. To see the full list of analyst forecasts on Novanta stock, see the NOVT Stock Forecast page.
Spark’s Take on NOVT Stock
According to Spark, TipRanks’ AI Analyst, NOVT is a Neutral.
Novanta’s strong financial performance and strategic positioning are key strengths, supported by solid earnings call insights. However, technical indicators and valuation suggest caution, with bearish trends and high P/E ratios. While long-term prospects are promising, short-term risks and overvaluation require attention.
To see Spark’s full report on NOVT stock, click here.
More about Novanta
Novanta Inc. is a trusted technology partner specializing in providing solutions for medical and advanced technology equipment manufacturers. The company operates in the technology industry, focusing on enhancing medical and industrial applications through its innovative products and services.
Average Trading Volume: 267,157
Technical Sentiment Signal: Sell
Current Market Cap: $4.16B
See more insights into NOVT stock on TipRanks’ Stock Analysis page.